Technology | Cardiovascular Ultrasound | August 22, 2018

Philips Launches Epiq CVx and CVxi Cardiovascular Ultrasound Systems

Epiq CVx line offers cardiologists tailored applications for diagnostic, pediatric and interventional echocardiography with faster data processing, sharper imaging, robust automated quantification and customizable exam tools

Philips Launches Epiq CVx and CVxi Cardiovascular Ultrasound Systems

August 22, 2018 — Philips recently announced the introduction of the Epiq CVx cardiovascular ultrasound system. Built on the Epiq ultrasound platform, Epiq CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients and reducing the need for repeat scans. According to Philips, 95 percent of a group of clinicians who were shown the new system believed it offered improved image quality: sharper and clearer images [1]. Philips is also introducing the Epiq CVxi, specifically tailored for use in the interventional lab. Both systems are CE marked and have received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

“The EPIQ CVx brings together advanced image quality, quantification and intelligence specifically for the cardiologist,” said Roberto Lang, M.D., professor of medicine, director, Noninvasive Cardiac Imaging Laboratory at the University of Chicago Medicine. “I was impressed with the TrueVue feature, which elevates 3-D ultrasound imaging to a totally new level and could impact diagnostic ability of echocardiography in different clinical scenarios, like better understanding of the anatomy of mitral valves.”

As pressures on healthcare systems around the world continue to increase, cardiologists have more patients to examine in less time, according to Philips. By using advanced 3-D organ modeling, image slicing and proven quantification, the company said its anatomical intelligence is helping make ultrasound exams easier to perform and more reproducible.

Philips described the Epiq CVxi as a third-generation integrated ultrasound-angiography cath lab solution for real-time, workflow-optimized image guidance and advanced quantification for structural heart procedures.

Debuting at the European Society of Cardiology (ESC) 2018 annual meeting, Aug. 25-29 in Munich, Germany, the Epiq CVx includes higher processing power, exceptional image clarity and sharpness, improved exam efficiencies, and more robust and reproducible quantification, enabled by anatomical intelligence. The system includes TrueVue, giving clinicians the ability to see photorealistic renderings of the heart, which improves cardiac anatomy analysis by offering detailed tissue and depth perception imaging through a new virtual light source. It provides cardiologists with high image quality through the latest generation OLED monitor, offering a more dynamic, wider viewing angle for side-by-side image comparison.

The system offers a variety of new features including Dynamic Heart Model. Building on Philips HeartModelA.I., it uses anatomical intelligence to automatically quantify left ventricle function to produce a multi-beat analysis for adult patients. Dynamic Heart Model has been shown to reduce the amount of time to generate a 3-D ejection fraction, an important measurement in determining how well the heart is pumping out blood, by 83 percent [2]. It also delivers a high level of robustness and reproducibility, even for patients with an arrhythmia. The systems also includes the new S9-2 PureWave Transducer, which simplifies pediatric cardiac imaging exams by displaying high levels of detail and contrast resolution through the single-crystal technology. It also provides tissue information at greater depths and enhances pediatric capability for coronary artery visualization.

The Epiq CVx includes a cardiology-specific user interface that simplifies the exam experience through a user-configurable touch-screen interface, allowing clinicians to personalize their controls and improve workflow for their cardiology exams. The system features strong security capabilities and protocols.

The Epiq CVxi with EchoNavigator, designed specifically for use in the cath lab, is Philips’ third-generation interventional solution to streamline communication between the interventional cardiologist and the echocardiographer during complex interventional exams. Combining live ultrasound and X-ray information into one intuitive view, EchoNavigator helps interventional cardiologists oversee procedures along with the location of key anatomical structures. In addition, MultiVue provides more flexibility when using 3-D during diagnostic or interventional procedures as the clinician can see multiple and flexible views at once.

For more information: www.usa.philips.com/healthcare

 

References

[1] Results obtained during user demonstrations performed in December 2017 with the Epiq CVx and the iE33 systems. The research was designed and supervised by Use-Lab GmbH, an independent and objective engineering consultancy and user interface design company. The tests involved 42 clinicians from 17 countries. The various types of cardiac customer segments represented were adult diagnostics and interventional, adult diagnostics, and pediatric diagnostics and interventional.

[2] Prado A, Narang A, Volpato V, Kumari N, Prater D, Addetia K, Patel AR, Mor-Avi V, Lang RM: Automated dynamic measurement of left heart chamber volumes for quantification of ejection and filling parameters. JASE 31(6):B111; 2018

 

Related Content

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

News | Coronavirus (COVID-19) | May 26, 2020
May 26, 2020  — Philips Healthcare recently received 510(k) clearance from the U.S.
An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019.

An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019. Photo by Dave Fornell.

News | Ultrasound Imaging | May 26, 2020
May 12, 2020 — DiA Imaging Analysis, a provider of AI based ultrasound analysis solutions, said it received a governm
Butterfly iQ devices provide revolutionary portable ultrasound capabilities for faster and easier screening and monitoring
News | Coronavirus (COVID-19) | May 20, 2020
May 20, 2020 —Atrium Health is one of the first major health systems in the nation to put into wide practice a new...
Richard J. Price, Ph.D., of the University of Virginia's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural 'blood-brain barrier,' which protects the brain from harmful pathogens. Photo courtesy of Dan Addison | UVA Communications

Richard J. Price, Ph.D., of the University of Virginia's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural 'blood-brain barrier,' which protects the brain from harmful pathogens. Photo courtesy of Dan Addison | UVA Communications

News | Focused Ultrasound Therapy | May 07, 2020
May 7, 2020 — University of Virginia researchers are pioneering the use of...
The new transducer reaches a 30% greater penetration, so clinicians have detailed images and performance they need to make a definitive diagnosis for pediatric patients, reducing the need for additional diagnostic imaging steps
News | Pediatric Imaging | May 06, 2020
May 6, 2020 — Philips announced the ...
Figure 4 for the study. Images of a 65-year-old man (patient 6). (a) Cardiac MRI perfusion shows perfusion deficit of anterior/anterolateral wall attributed to left anterior descending artery/left circumflex artery (*). (b) CT coronary angiography. (c) Coronary angiography, left anterior oblique projection with caudal angulation. (d) Three-dimensional image fusion helped refine diagnosis: perfusion deficits (*) were most likely caused by narrow first diagonal branch and its first, stented side branch.

Figure 4 for the study. Images of a 65-year-old man (patient 6). (a) Cardiac MRI perfusion shows perfusion deficit of anterior/anterolateral wall attributed to left anterior descending artery/left circumflex artery (*). (b) CT coronary angiography. (c) Coronary angiography, left anterior oblique projection with caudal angulation. (d) Three-dimensional image fusion helped refine diagnosis: perfusion deficits (*) were most likely caused by narrow first diagonal branch and its first, stented side branch (arrowhead). Retrospectively, denoted lesion could also be found at CT coronary angiography and coronary angiography (arrowheads in b and c, respectively). CT FFR = CT-derived fractional flow reserve, LGE = late gadolinium enhancement. Image courtesy of RSNA, Radiology.

News | Cardiac Imaging | May 04, 2020
May 4, 2020 – A new technique that combines computed tomography (CT) and magnetic resonance imaging MRI can bolster c
Konica Minolta Healthcare's Rede Mini PACS are designed for specialty practices such as orthopedic, urgent care and family medicine clinics
News | PACS | April 28, 2020
April 28, 2020 – Konica Minolta Healthcare Americas released its Rede...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

News | Coronavirus (COVID-19) | April 24, 2020
April 24, 2020 — The Food and Drug Administration (FDA or the Agency) plays a critic
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Pulmonary CT angiography of a 68 year old male. The CT scan was obtained 10 days after the onset of COVID-19 symptoms and on the day the patient was transferred to the intensive care unit.

Figure 2: Pulmonary CT angiography of a 68 year old male. The CT scan was obtained 10 days after the onset of COVID-19 symptoms and on the day the patient was transferred to the intensive care unit. Axial CT images (lung windows) (a,b) show peripheral ground-glass opacities (arrow) associated with areas of consolidation in dependent portions of the lung (arrowheads). Interlobular reticulations, bronchiectasis (black arrow) and lung architectural distortion are present. Involvement of the lung volume was estimated to be between 25% and 50%. Coronal CT reformations (mediastinum windows) (c,d) show bilateral lobar and segmental pulmonary embolism (black arrows). Courtesy of RSNA

News | Coronavirus (COVID-19) | April 23, 2020
April 23, 2020 — A special report p